Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.
about
Antimuscarinic Use in Females With Overactive Bladder Syndrome Increases the Risk of Depressive Disorder: A 3-Year Follow-up Study.Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study.Inhibition of salivary secretion by tolterodine transdermal patch.Muscarinic receptors mediate cold stress-induced detrusor overactivity in type 2 diabetes mellitus rats.Analytical Method Development and Validation of Solifenacin in Pharmaceutical Dosage Forms by RP-HPLCBioanalytical method for quantification of Solifenacin in rat plasma by LC-MS/MS and its application to pharmacokinetic study
P2860
Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Characterization of bladder se ...... in vivo drug-receptor binding.
@en
Characterization of bladder se ...... in vivo drug-receptor binding.
@nl
type
label
Characterization of bladder se ...... in vivo drug-receptor binding.
@en
Characterization of bladder se ...... in vivo drug-receptor binding.
@nl
prefLabel
Characterization of bladder se ...... in vivo drug-receptor binding.
@en
Characterization of bladder se ...... in vivo drug-receptor binding.
@nl
P2093
P2860
P1476
Characterization of bladder se ...... in vivo drug-receptor binding.
@en
P2093
Ayaka Osano
Shiori Kuraoka
Shizuo Yamada
Yoshihiko Ito
P2860
P304
P356
10.5213/INJ.2012.16.3.107
P577
2012-09-30T00:00:00Z